Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Heymann

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Journal of Travel Medicine|June 2, 2020
Successful smallpox eradication: what can we learn to control COVID-19?D L Heymann, Annelies Wilder-Smith
The Lancet. Infectious Diseases|March 2, 2002
Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseasesD L Heymann, G R Rodier,
Medecine Tropicale : Revue Du Corps De Sante Colonial|January 1, 1979
[A controlled experience with a thermostabile measles vaccine in Cameroon (author's transl)]D L Heymann, J Nakano, B Durand
British Medical Bulletin|May 18, 1999
Re-emergence of monkeypox in Africa: a review of the past six yearsD L Heymann, M Szczeniowski, K Esteves
The New England Journal of Medicine|June 24, 1993
CD4+ T-lymphocytopenia without HIV infectionD L Heymann, E Belsey, J G Esparza
Annals of the New York Academy of Sciences|February 3, 1999
Monitoring infectious diseasesF X Meslin, D L Heymann, C Witt
Journal of Clinical Microbiology|November 1, 1981
Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveysK M Johnson, L H Elliott, D L Heymann
Bulletin of the World Health Organization|January 1, 1991
Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health OrganizationD J Hu, M A Kane, D L Heymann
Bulletin of the World Health Organization|January 1, 1984
Gonococcal ophthalmia neonatorum: the case for prophylaxis in tropical AfricaF P Galega, D L Heymann, B T Nasah
AIDS (London, England)|January 1, 1993
Treatment, prophylaxis and research priorities for developing countriesD L Heymann, J J Wirima, J H Perriëns
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Journal of Travel Medicine|June 2, 2020
Successful smallpox eradication: what can we learn to control COVID-19?D L Heymann, Annelies Wilder-Smith
The Lancet. Infectious Diseases|March 2, 2002
Hot spots in a wired world: WHO surveillance of emerging and re-emerging infectious diseasesD L Heymann, G R Rodier,
Medecine Tropicale : Revue Du Corps De Sante Colonial|January 1, 1979
[A controlled experience with a thermostabile measles vaccine in Cameroon (author's transl)]D L Heymann, J Nakano, B Durand
British Medical Bulletin|May 18, 1999
Re-emergence of monkeypox in Africa: a review of the past six yearsD L Heymann, M Szczeniowski, K Esteves
The New England Journal of Medicine|June 24, 1993
CD4+ T-lymphocytopenia without HIV infectionD L Heymann, E Belsey, J G Esparza
Annals of the New York Academy of Sciences|February 3, 1999
Monitoring infectious diseasesF X Meslin, D L Heymann, C Witt
Journal of Clinical Microbiology|November 1, 1981
Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveysK M Johnson, L H Elliott, D L Heymann
Bulletin of the World Health Organization|January 1, 1991
Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health OrganizationD J Hu, M A Kane, D L Heymann
Bulletin of the World Health Organization|January 1, 1984
Gonococcal ophthalmia neonatorum: the case for prophylaxis in tropical AfricaF P Galega, D L Heymann, B T Nasah
AIDS (London, England)|January 1, 1993
Treatment, prophylaxis and research priorities for developing countriesD L Heymann, J J Wirima, J H Perriëns
Pageof 7